Skip to main content

Echo Therapeutics, Inc. (ECTE)

Sep 8, 2021 - ECTE was delisted (reason: registration revoked by SEC)
0.0002 0.0000 (0.00%)
Sep 3, 2021 9:30 AM EDT - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year2015201420132012201120102009200820072006
Revenue
00.060.030.010.450.431.3300.060.09
Revenue Growth
-107.68%439.17%-98.86%4.38%-67.83%---34.88%-
Cost of Revenue
0000000000.09
Gross Profit
00.060.030.010.450.431.3300.06-0
Selling, General & Admin
4.337.356.686.374.912.763.053.744.62.11
Research & Development
2.794.6312.998.673.82.582.813.191.313.06
Other Operating Expenses
10.430.390000006.990.28
Operating Expenses
17.5412.3819.6715.058.75.345.866.9312.95.44
Operating Income
-17.54-12.32-19.64-15.04-8.25-4.91-4.53-6.93-12.85-5.45
Interest Expense / Income
0.0203.90.50.010.040.331.050.440.02
Other Expense / Income
4.642.64-4.48-3.211.76-0.86.12.62-0.06-0.12
Pretax Income
-22.19-14.96-19.07-12.33-10.03-4.15-10.96-10.6-13.23-5.34
Income Tax
0000000000
Net Income
-22.2-14.96-19.07-12.33-10.03-4.15-10.96-10.6-13.23-5.34
Preferred Dividends
00.350.3706.690.132.550.0500.01
Net Income Common
-22.2-15.31-19.44-12.33-16.72-4.28-13.51-10.65-13.23-5.35
Shares Outstanding (Basic)
111284332210
Shares Outstanding (Diluted)
111284332210
Shares Change
-8.75%47.23%111.37%15.73%17.72%30.24%19.79%58.11%332.68%-
EPS (Basic)
-1.98-1.24-2.33-3.12-4.89-1.50-6.10-5.70-11.20-19.70
EPS (Diluted)
-1.98-1.24-2.33-3.12-4.89-1.50-6.10-5.70-11.20-19.70
Free Cash Flow Per Share
-0.45-0.87-2.35-2.98-2.12-1.25-1.03-2.13-2.18-18.50
Gross Margin
-100.00%100.00%100.00%100.00%100.00%100.00%-97.32%-1.76%
Operating Margin
--21494.81%-71177.12%-293807.77%-1845.81%-1146.07%-340.15%--22164.91%-6118.61%
Profit Margin
--26103.27%-69084.77%-240906.58%-2242.70%-967.84%-822.73%--22821.08%-6001.42%
Free Cash Flow Margin
--18773.63%-71227.69%-230020.63%-1620.99%-850.54%-172.31%--4421.63%-5655.13%
Effective Tax Rate
-0.02%-0.03%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBITDA
-21.66-14.56-14.77-11.68-9.97-4-10.47-9.35-12.64-5.14
EBITDA Margin
--25409.10%-53524.22%-228208.54%-2228.87%-933.54%-785.93%--21807.37%-5772.88%
EBIT
-22.18-14.96-15.16-11.83-10.02-4.11-10.63-9.55-12.79-5.32
EBIT Margin
--26094.24%-54943.05%-231044.15%-2239.58%-959.07%-797.84%--22068.91%-5979.12%
Showing 10 of 20 years
10 more years are available
Start Free Trial
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).